Symptomatic management in multiple sclerosis |
| |
Authors: | Samkoff Lawrence M Goodman Andrew D |
| |
Affiliation: | Department of Neurology, University of Rochester School of Medicine and Dentistry, Rochester, NY, USA |
| |
Abstract: | The development of immunomodulatory therapies for multiple sclerosis (MS) has had significant impact in altering the natural history of the disease. Although these agents reduce relapse rate and MRI-associated disease activity, they are only partially effective and do not ameliorate irreversible axonal injury, which produces much of the symptomatic burden of MS. Treatment of MS-associated symptoms remains an essential cornerstone of comprehensive care of patients with MS and, arguably, more favorably enhances quality of life than do the disease-modifying medications. This article reviews strategies of symptom management in patients with MS. |
| |
Keywords: | Multiple sclerosis Immunomodulatory therapies Symptom management Urinary tract dysfunction |
本文献已被 ScienceDirect PubMed 等数据库收录! |